Publications by authors named "Canan Nebigil"

Claim this Profile
C
Corrigendum to "Targeting prohibitin with small molecules unravels a common signaling pathway for melanogenesis and apoptosis in melanoma cells" [Eur. J. Med. Chem. 155 (2018) 880].
Amel Djehal, Mohammad Krayem, Ahmad Najem, Hassan Hammoud, Thierry Cresteil, Canan G Nebigil

Eur J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prokineticin-2 as potential pharmacodynamic biomarker for overcoming doxorubicin resistance in multicellular breast cancer spheroids.
Martina Vincenzi, Amin Kremic, Nathalie N Tscheiller, Po-Yen Hsu, Michael W Y Chan, Canan G Nebigil

Br J Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathy.
Martina Vincenzi, Canan G Nebigil

Trends Cardiovasc Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Martina Vincenzi, Amin Kremić, Appoline Jouve, Roberta Lattanzi, Rossella Miele, Canan G Nebigil

Pharmacol Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The flavagline FL3 interferes with the association of Annexin A2 with the eIF4F initiation complex and transiently stimulates the translation of A2 mRNA.
Ann Kari Grindheim, Sudarshan S Patil, Canan G Nebigil, Laurent Désaubry, Anni Vedeler

Front Cell Dev Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer.
Canan G Nebigil, Michael W Y Chan

Front Cardiovasc Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.
Nora Chouha, Hussein Abou-Hamdan, Hajime Yurugi, Riku Yoshii, Hiromi Ii, Canan G Nebigil

Eur J Med Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for reciprocal network interactions between injured hearts and cancer.
Melisa N Guler, Nathalie M Tscheiller, Maria Sabater-Molina, Juan R Gimeno, Canan G Nebigil

Front Cardiovasc Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Pierre Antony, Sylvie Fournel, Joffrey Zoll, Jean-Marie Mantz, Katia Befort

Biol Aujourdhui· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies.
Po-Yen Hsu, Aynura Mammadova, Nadia Benkirane-Jessel, Laurent Désaubry, Canan G Nebigil

Front Cardiovasc Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies.
Ferda Demir, Kyoji Urayama, Anais Audebrand, Ayca Toprak-Semiz, Marja Steenman, Canan G Nebigil

Hypertension· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nguyen T.L., et al. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. 2013, , 20-31.
Thu Lan Nguyen, Adeline Gasser, Canan G Nebigil

J Dev Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFPH proteins as therapeutic targets for a myriad of diseases.
Dong Wang, Redouane Tabti, Sabria Elderwish, Amel Djehal, Nora Chouha, Canan G Nebigil

Bioorg Med Chem Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.
Canan G Nebigil, Christiane Moog, Stéphan Vagner, Nadia Benkirane-Jessel, Duncan R Smith

Eur J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries.
Laurent Désaubry, Anumantha G Kanthasamy, Canan G Nebigil

Pharmacol Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.
Dong Wang, Redouane Tabti, Sabria Elderwish, Hussein Abou-Hamdan, Amel Djehal, Canan G Nebigil

Cell Mol Life Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside.
Canan G Nebigil, Michael W Y Chan, Tienush Rassaf

Front Cardiovasc Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.
Sabria Elderwish, Anaïs Audebrand, Canan G Nebigil, Laurent Désaubry

Eur J Med Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments.
Anais Audebrand, Laurent Désaubry, Canan G Nebigil

Front Cardiovasc Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection.
Adeline Gasser, Yu-Wen Chen, Anais Audebrand, Ayhan Daglayan, Marine Charavin, Canan G Nebigil

JACC CardioOncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT).
Canan G Nebigil, Laurent Désaubry

Trends Cardiovasc Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in Anthracycline-Mediated Cardiotoxicity.
Canan G Nebigil, Laurent Désaubry

Front Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prokineticin-Driven Epigenetic Switch Regulates Human Epicardial Cell Stemness and Fate.
Rehana Qureshi, Michel Kindo, Mounia Boulberdaa, Jean-Jacques von Hunolstein, Marja Steenman, Canan G Nebigil

Stem Cells· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.
Amel Djehal, Mohammad Krayem, Ahmad Najem, Hassan Hammoud, Thierry Cresteil, Canan G Nebigil

Eur J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21 fibroblast progenitor cell transformation into adipocytes and vascular cells.
Rehana Qureshi, Michel Kindo, Himanshu Arora, Mounia Boulberdaa, Marja Steenman, Canan G Nebigil

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis